Cardiovascular injury and repair in chronic obstructive pulmonary disease.
暂无分享,去创建一个
[1] Albert Hofman,et al. Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study , 2006, Circulation.
[2] P. Ducimetiere,et al. Reduced pulmonary function is associated with central arterial stiffness in men. , 2001, American journal of respiratory and critical care medicine.
[3] D. Webb,et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. , 1999, Circulation.
[4] S. Sidney,et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. , 2005, Chest.
[5] T. Omland,et al. Statin use is associated with reduced mortality in COPD , 2006, European Respiratory Journal.
[6] W. MacNee,et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk , 2007, Thorax.
[7] M. Tschöp,et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. , 2000, Cytokine.
[8] T. Aw,et al. Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. , 1997, Circulation research.
[9] D. Sin,et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[10] D. Celermajer,et al. Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. , 2005, Atherosclerosis.
[11] E. Silverman,et al. Smoking related COPD and facial wrinkling: Is there a common susceptibility?: Thorax 2006;61:568–671 , 2006 .
[12] H. Wedel,et al. Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. , 1986, American journal of epidemiology.
[13] M. Pfeffer,et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. , 2000, Circulation.
[14] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[15] D. Sin,et al. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. , 2005, Chest.
[16] V. Pasceri,et al. C-reactive protein: linking inflammation to cardiovascular complications. , 2001, Circulation.
[17] R. Peters,et al. IL-8 Plasma Concentrations and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[18] A. Schols,et al. Systemic effects in COPD. , 2002, Chest.
[19] W. Kannel,et al. Mortality associated with respiratory function and symptoms in advanced age. The Framingham Study. , 1989, The American review of respiratory disease.
[20] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[21] N. Samani,et al. Expanding the concept of telomere dysfunction in cardiovascular disease. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[22] K. Node,et al. Vascular failure: a new clinical entity for vascular disease , 2006, Journal of hypertension.
[23] Anthony P Reeves,et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. , 2007, American journal of respiratory and critical care medicine.
[24] S. Suissa,et al. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD , 2005, European Respiratory Journal.
[25] C. Balke,et al. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. , 2005, American journal of respiratory and critical care medicine.
[26] Kazuhisa Takahashi,et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. , 2006, American journal of respiratory and critical care medicine.
[27] E. Piitulainen,et al. Circulating monocytes from healthy individuals and COPD patients , 2003, Respiratory research.
[28] K L Ebi-Kryston,et al. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. , 1988, Journal of clinical epidemiology.
[29] R. Hopkins,et al. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes , 2007, European Respiratory Journal.
[30] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[31] M. Blasco,et al. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres , 1999, The EMBO journal.
[32] W. Bailey,et al. Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.
[33] James E. Johnson,et al. Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD , 2007, Thorax.
[34] X. Busquets,et al. Enhanced neutrophil response in chronic obstructive pulmonary disease , 2001, Thorax.
[35] J. O’Keefe,et al. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. , 2002, Mayo Clinic proceedings.
[36] K. Ozasa,et al. ASSOCIATION OF LUNG FUNCTION WITH ATHEROSCLEROTIC RISK FACTORS AMONG JAPANESE AMERICANS: SEATTLE NIKKEI HEALTH STUDY , 2004, Clinical and experimental pharmacology & physiology.
[37] V. Peinado,et al. Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory cell and molecular biology.
[38] T. Shim,et al. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. , 2005, American journal of respiratory and critical care medicine.
[39] C. Lenfant,et al. Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .
[40] X. Busquets,et al. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[41] B. Hedblad,et al. Lung Function and Cardiovascular Risk: Relationship With Inflammation-Sensitive Plasma Proteins , 2002, Circulation.
[42] A. Agustí,et al. Telomere shortening in smokers with and without COPD , 2006, European Respiratory Journal.
[43] T. Assimes,et al. Inhaled short acting β agonist use in COPD and the risk of acute myocardial infarction , 2003, Thorax.
[44] Ferdinand J. Venditti,et al. Reduced Heart Rate Variability and Mortalit Risk in an Elderly Cohort: The Framingham Heart Study , 1994, Circulation.
[45] Jianguo Li,et al. Chronic intermittent hypoxia induces atherosclerosis. , 2007, American journal of respiratory and critical care medicine.
[46] D. Sin,et al. The interactions between cigarette smoking and reduced lung function on systemic inflammation. , 2005, Chest.
[47] M. Etminan,et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. , 2006, Journal of the American College of Cardiology.
[48] Jeroen J. Bax,et al. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. , 2008, American journal of respiratory and critical care medicine.
[49] R. Nagai,et al. Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. , 2000, American journal of respiratory cell and molecular biology.
[50] M. Cosio,et al. Hypothesis: Does COPD have an autoimmune component? , 2003, Thorax.
[51] E. Benjamin,et al. Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[52] Stéphane Cook,et al. High heart rate: a cardiovascular risk factor? , 2006, European heart journal.
[53] J. Ornato,et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.
[54] N. Thomson,et al. Potential therapeutic role for statins in respiratory disease , 2006, Thorax.
[55] D. Sin,et al. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[56] S. Fichtlscherer,et al. Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.
[57] J. Berger,et al. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. , 2004, The American journal of cardiology.
[58] M. O'Rourke,et al. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. , 1990, Hypertension.
[59] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[60] W. MacNee,et al. Effects of hypoxia on renal hormonal balance in normal subjects and in patients with COPD. , 1998, Respiratory medicine.
[61] T. Truelsen,et al. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. , 2001, International journal of epidemiology.
[62] Nancy R Cook,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.
[63] A. Quyyumi,et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.
[64] S. Laurent,et al. Aortic Stiffness Is an Independent Predictor of Fatal Stroke in Essential Hypertension , 2003, Stroke.
[65] W. MacNee,et al. Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.
[66] B. Gersh. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study , 2008 .
[67] A Senthilselvan,et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.
[68] T. Zglinicki,et al. Replicative Aging, Telomeres, and Oxidative Stress , 2002, Annals of the New York Academy of Sciences.
[69] W. Bailey,et al. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. , 2008, Thorax.
[70] R. Cawthon,et al. Association between telomere length in blood and mortality in people aged 60 years or older , 2003, The Lancet.
[71] G. Hasenfuss,et al. Marked sympathetic activation in patients with chronic respiratory failure. , 2001, American journal of respiratory and critical care medicine.
[72] J. Janssens,et al. Physiological changes in respiratory function associated with ageing. , 1999, The European respiratory journal.
[73] Lieu Tl,et al. Obesity, cigarette smoking, and telomere length in women , 2005 .
[74] S. Laurent,et al. Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients: A Longitudinal Study , 2002, Hypertension.
[75] E. Metter,et al. Rapid decline in FEV1. A new risk factor for coronary heart disease mortality. , 1995, American journal of respiratory and critical care medicine.
[76] A. Luttun,et al. Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth , 2004, Circulation.
[77] L. Fabbri,et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease , 2006, Thorax.
[78] A. Hofman,et al. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. , 2004, Atherosclerosis.
[79] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[80] A. Aviv. Telomeres and human somatic fitness. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[81] S. Devaraj,et al. C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis , 2003, Circulation.
[82] B. Hemmelgarn,et al. Bronchodilators and acute cardiac death. , 1996, American journal of respiratory and critical care medicine.
[83] S. Shapiro,et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.
[84] M. Lebowitz,et al. Death certificate reporting of confirmed airways obstructive disease. , 1991, American journal of epidemiology.
[85] S. Verma,et al. Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein , 2002, Circulation.
[86] T. Meade,et al. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. , 2007, European heart journal.
[87] R. Peto,et al. The natural history of chronic airflow obstruction. , 1977, British medical journal.
[88] D. Hartmann,et al. Changes in the elastic tissue of the non‐sun‐exposed skin of cigarette smokers , 1991, The British journal of dermatology.
[89] T. Tsuji,et al. Alveolar cell senescence in patients with pulmonary emphysema. , 2006, American journal of respiratory and critical care medicine.
[90] S. Scalvini,et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. , 1994, Chest.
[91] Peter Libby,et al. Inflammatory mechanisms: the molecular basis of inflammation and disease. , 2007, Nutrition reviews.
[92] P. Palange,et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD , 2006, European Respiratory Journal.
[93] F. Bonomini,et al. Atherosclerosis and oxidative stress. , 2008, Histology and histopathology.
[94] W. Koenig,et al. C-Reactive Protein in the Arterial Intima: Role of C-Reactive Protein Receptor–Dependent Monocyte Recruitment in Atherogenesis , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[95] C. Tribouilloy,et al. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. , 2008, The American journal of cardiology.
[96] Tadashi Kaname,et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.
[97] E. Wouters,et al. Raised CRP levels mark metabolic and functional impairment in advanced COPD , 2005, Thorax.
[98] T. Minamino,et al. Mechanisms of Telomerase Induction During Vascular Smooth Muscle Cell Proliferation , 2001, Circulation research.
[99] J. Skurnick,et al. Age dependent aneuploidy and telomere length of the human vascular endothelium. , 2001, Atherosclerosis.
[100] K. Griendling,et al. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. , 2007, Trends in cardiovascular medicine.
[101] C. O'connor,et al. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. , 1997, Thorax.
[102] E. Wouters. Local and systemic inflammation in chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.
[103] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[104] D. Webb,et al. Effects of short-term isocapnic hyperoxia and hypoxia on cardiovascular function. , 2006, Journal of applied physiology.
[105] J. Skurnick,et al. Telomere Length as an Indicator of Biological Aging: The Gender Effect and Relation With Pulse Pressure and Pulse Wave Velocity , 2001, Hypertension.
[106] P. Libby,et al. Pathophysiology of Coronary Artery Disease , 2005, Circulation.
[107] Sridevi Devaraj,et al. Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells , 2002, Circulation.
[108] V. Peinado,et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[109] A. Evans,et al. C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease: The PRIME Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[110] S. Teramoto,et al. Aging, the aging lung, and senile emphysema are different. , 2007, American journal of respiratory and critical care medicine.
[111] Robert A Wise,et al. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee , 2007, Thorax.
[112] Yasmin,et al. Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[113] G. Tsirpanlis. Cellular senescence, cardiovascular risk, and CKD: a review of established and hypothetical interconnections. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[114] A. Folsom,et al. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. , 2006, Chest.
[115] S. Bojesen,et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[116] W. Markiewicz,et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. , 2006, American journal of respiratory and critical care medicine.
[117] M. Egred,et al. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease. , 2005, QJM : monthly journal of the Association of Physicians.
[118] J. Spertus,et al. Impact of Chronic Obstructive Pulmonary Disease on Post-Myocardial Infarction Outcomes: P201 , 2006, The American journal of cardiology.
[119] [Population study of women in Gothenburg]. , 1981, Lakartidningen.
[120] P M Rautaharju,et al. Cardiac Infarction Injury Score: An Electrocardiographic Coding Scheme for Ischemic Heart Disease , 1981, Circulation.
[121] S. Suissa,et al. Cardiovascular morbidity and mortality in COPD. , 2005, Chest.
[122] Peter H Edwards,et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[123] M. Blasco,et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation , 2003, The EMBO journal.
[124] V M Hawthorne,et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study , 1996, BMJ.
[125] Judith K Jones,et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. , 2006, Annals of epidemiology.
[126] S. Antoniu,et al. Hospitalizations and mortality in the Lung Health Study , 2002, Expert review of pharmacoeconomics & outcomes research.
[127] E. Blackburn,et al. Telomeres and telomerase. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[128] S. Gottlieb,et al. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.
[129] E. Silverman,et al. Smoking related COPD and facial wrinkling: is there a common susceptibility? , 2006, Thorax.
[130] D. Sin,et al. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. , 2003, Circulation.
[131] P. Ridker,et al. Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score , 2003, Circulation.
[132] H. Coxson,et al. Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.
[133] B. Hedblad,et al. Respiratory Decline in Smokers and Ex-Smokers — An Independent Risk Factor for Cardiovascular Disease and Death , 2000, Journal of cardiovascular risk.
[134] R. Mecham,et al. The stumbling block in lung repair of emphysema: elastic fiber assembly. , 2006, Proceedings of the American Thoracic Society.
[135] C. Vogelmeier,et al. Chronic obstructive pulmonary disease and premature aging. , 2007, American journal of respiratory and critical care medicine.
[136] G GUIMARAES,et al. Essential hypertension , 1950, Revue de medecine aeronautique.
[137] T. Matsuo,et al. Telomere Shortening in Human Coronary Artery Diseases , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[138] D. Kass,et al. Mechanisms, pathophysiology, and therapy of arterial stiffness. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[139] Yasmin,et al. Variation in the Human Matrix Metalloproteinase-9 Gene Is Associated With Arterial Stiffness in Healthy Individuals , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[140] G. Hunninghake,et al. Cigarette smoke induces cellular senescence. , 2006, American journal of respiratory cell and molecular biology.
[141] E. Salpeter,et al. Cardioselective beta-blockers for chronic obstructive pulmonary disease. , 2005, The Cochrane database of systematic reviews.
[142] A. Agustí. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). , 2007, Proceedings of the American Thoracic Society.
[143] Lippincott Williams Wilkins,et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .
[144] J. Curtis,et al. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. , 2002, Chest.